Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.
about
Advax-adjuvanted recombinant protective antigen provides protection against inhalational anthrax that is further enhanced by addition of murabutide adjuvantThe Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in MiceAdvax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single-dose influenza vaccine protectionAdvax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety.Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant.Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of an delta inulin adjuvanted recombinant pandemic influenza vaccine.Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvantThe polysaccharide inulin is characterized by an extensive series of periodic isoforms with varying biological actions.Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets.Gamma ray sterilization of delta inulin adjuvant particles (Advax™) makes minor, partly reversible structural changes without affecting adjuvant activity.Inulin isoforms differ by repeated additions of one crystal unit cell.A single immunization with inactivated H1N1 influenza vaccine formulated with delta inulin adjuvant (Advax™) overcomes pregnancy-associated immune suppression and enhances passive neonatal protectionImmunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study.Inulin crystal initiation via a glucose-fructose cross-link of adjacent polymer chains: atomic force microscopy and static molecular modelling.Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foalsCarbohydrate-based immune adjuvants.Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.Analysis of the hydrolysis of inulin using real time 1H NMR spectroscopy.Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses.Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future NeedsApplications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibodyPhysical characterization and in silico modeling of inulin polymer conformation during vaccine adjuvant particle formation.An inactivated cell culture Japanese encephalitis vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against West Nile encephalitis via cross-protective memory B cells and neutralizing antibodyDelta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology.Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines.Application and use of Inulin as a tool for therapeutic drug delivery.Carbohydrate-based vaccine adjuvants - discovery and development.Implications of plant glycans in the development of innovative vaccines.Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection.Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant.Advax4 delta inulin combination adjuvant together with ECMX, a fusion construct of three protective mTB antigens, induces a potent Th1 immune response and protects mice against Mycobacterium tuberculosis infection.Insights into furanose solution conformations: beyond the two-state model.Vaccine adjuvant safety: the elephant in the room.Chemically modified inulin microparticles serving dual function as a protein antigen delivery vehicle and immunostimulatory adjuvant.
P2860
Q28384323-DE6F05B3-1E15-4156-9DDD-A4DB9C55138CQ28552440-3D804147-3BB5-4D98-86D9-3DA2752F9BA0Q30377381-EC51E65B-746D-4A51-BA5E-C9259171BE61Q30379559-D2462230-AEFD-47DA-975B-795F454832A1Q30389743-878D24E3-0AEB-41EB-B3AD-65CA852D9931Q30399988-ACC50253-8829-4314-A534-7FE0D175B836Q30418297-FA5F78B9-B529-4E0C-A128-750F2B363CE5Q30655287-BB48E4CC-DD2E-4893-A961-E17E516149E2Q33396140-CAB80D16-102D-4911-A091-CD54DF6456E9Q33718615-2C7ED547-38DD-43DB-AA75-B4A2B9BAAAD3Q33735067-F839D381-17A0-4D14-89AC-57BBA501B988Q33940730-A338DBBB-8EB9-4680-A05E-7C4DE368E5DFQ34621859-D6DB10B0-711A-47F7-A154-769CBEE530FDQ34719089-06D15A1B-4F48-4BDB-AAF4-F5ED39B1ADCEQ34720701-D1F5E070-3FA5-42F8-B467-2FFE8918BE18Q35054845-C6F953E1-45BC-4AE3-923B-3AD163BC187CQ35111000-422A7C4F-1CAF-4570-8BA8-9643A9A22D87Q35883975-51AE9302-4A48-46CB-BAB3-59E756134D21Q36106655-C2C31500-EB05-485F-B4DF-49F88717B7FEQ36191001-7AE274DF-657C-472C-AEB5-358DA106635BQ36591050-F9AF3BB7-0AC0-495E-947C-79DC2FED1F2BQ36760059-34E06AA3-1E9F-4FA7-BECD-B11C81F21006Q36805270-24BCE821-3059-48A6-B41A-9DF448C5B53CQ37123147-4A38BD65-0874-4663-B5C3-CAD7A1661BBAQ37197103-DE98DF97-F793-4059-ABD4-29354CBDED21Q37584248-8CA99493-A27A-4592-9001-EC077E78C8D5Q38012147-D1CC2AFC-3E81-430D-BD7A-9B85704385D8Q38587300-D000E257-8F3A-4CB3-8502-20211C8D0BF7Q38738762-593C668D-9B7B-4901-9B9D-5CCBCB532A81Q40089069-C2D78580-14D8-47EA-B0A2-0F9A2D385A66Q40715781-0DA470C8-D8E9-47B5-B4C0-FEE92DE19A55Q41995267-239B3FEF-E4BD-47D8-95F2-3D2DE5FA0957Q42284278-E6A5A512-F5E2-4DD4-9342-CBB144D4DA3EQ44538019-D6FFF2FB-B5F6-4197-B8CB-75FB82393011Q51567300-B48AC588-216D-4DE5-ADEC-82C0E33D0809
P2860
Delta inulin: a novel, immunologically active, stable packing structure comprising β-D-[2 -> 1] poly(fructo-furanosyl) α-D-glucose polymers.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Delta inulin: a novel, immunol ...... ranosyl) α-D-glucose polymers.
@ast
Delta inulin: a novel, immunol ...... ranosyl) α-D-glucose polymers.
@en
type
label
Delta inulin: a novel, immunol ...... ranosyl) α-D-glucose polymers.
@ast
Delta inulin: a novel, immunol ...... ranosyl) α-D-glucose polymers.
@en
prefLabel
Delta inulin: a novel, immunol ...... ranosyl) α-D-glucose polymers.
@ast
Delta inulin: a novel, immunol ...... ranosyl) α-D-glucose polymers.
@en
P2860
P356
P1433
P1476
Delta inulin: a novel, immunol ...... ranosyl) α-D-glucose polymers.
@en
P2093
Peter D Cooper
P2860
P304
P356
10.1093/GLYCOB/CWQ201
P577
2010-12-07T00:00:00Z